Advertisement

Royal Philips Electronics (NYSE: PHG) of Andover has announced that the FDA approved a clinical study of a product to ease pain caused by lung, prostate or breast cancers which the company developed in partnership with Celsion Corp. in New Jersey.

Advertisement
Advertisement